STOCK OPTIONS AND WARRANTS (Details 3) |
6 Months Ended |
---|---|
Jun. 30, 2024
$ / shares
shares
| |
Exercisable, Number of Options | 994,979 |
Warrants Outstanding [Member] | |
Exercise price | $ / shares | $ 3.16 |
Weighted average remaining life in years | 2 years 3 months 18 days |
Number of outstanding | 1,765,856 |
Warrants Outstanding [Member] | 3.16 [Member] | |
Exercise price | $ / shares | $ 3.16 |
Weighted average remaining life in years | 2 years 3 months 18 days |
Number of outstanding | 1,765,856 |
Warrants Exercisable [Member] | |
Exercisable, Number of Options | 1,765,856 |
Exercise price | $ / shares | $ 3.16 |
Weighted average remaining life in years | 2 years 3 months 18 days |
Warrants Exercisable [Member] | 3.16 [Member] | |
Exercisable, Number of Options | 1,765,856 |
Exercise price | $ / shares | $ 3.16 |
Weighted average remaining life in years | 2 years 3 months 18 days |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|